PVs and LPVs in BRCA1/2 genes cover a percentage ranging from 20 to 25% of all hereditary breast cancers (BCs) and about 5–10% of all BCs [1] and are correlated to an increased risk of developing some types of aggressive carcinomas. This evidence concerns the gene BRCA1 and carcinoma.